Thomas E. Bonney

This profile gathers the share dealings of Thomas E. Bonney in Novadel Pharma Inc. In total, 4 filings cover trades dated from 30 June 2006 to 31 August 2007.

The open-market record is one-sided, with 4 purchases worth €27k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2007 to date brings 3 purchases and no sales.

A typical purchase (the median) is worth €3,069.

The latest filing, published on 4 September 2007, reports an open-market purchase of €3,069 in Novadel Pharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.